Výsledky vyhledávání - "Sumeet Attri"

Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

Autor: Gary T. Ferguson, Ulf Holmgren, M.K. Siddiqui, Barinder Singh, Enrico De Nigris, Sumeet Attri, Shaila Ballal, Patrick Darken

Publikováno v: Advances in Therapy. 37:2956-2975

Triple inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β2-agonist (ICS/LAMA/LABA) combination therapy is recommended for patients with chronic obstructive pulmonary disease (COPD) who experience further exacerbations/symptoms on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a92ceecafb8f25db994edf6c2d51f62c
https://doi.org/10.1007/s12325-020-01311-3

Zobrazit plný text záznamu

Cost-Effectiveness of Rifaximin-α versus Lactulose for the Treatment of Recurrent Episodes of Overt Hepatic Encephalopathy: A Meta-Analysis

Autor: Kashif Mohd Siddiqui, Sumeet Attri, Massimo Orlando, Filippo Lelli, Valeria Maida, Dominique Damais-Thabut

Publikováno v: GastroHep.

Background. Hepatic encephalopathy (HE) is a frequent and debilitating complication of liver disease. Treatments include lactulose and rifaximin-α. The objective of this literature review and meta-analysis was to assess the overall cost-effectivenes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d7ee2273be8bd922afd68f1f496c498

Zobrazit plný text záznamu

Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β

Autor: Gary T, Ferguson, Patrick, Darken, Shaila, Ballal, Mohd Kashif, Siddiqui, Barinder, Singh, Sumeet, Attri, Ulf, Holmgren, Enrico, de Nigris

Publikováno v: Advances in Therapy

Introduction Triple inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β2-agonist (ICS/LAMA/LABA) combination therapy is recommended for patients with chronic obstructive pulmonary disease (COPD) who experience further exacerbation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5ae8d601635a9395a7e2106bf7e4e337
https://pubmed.ncbi.nlm.nih.gov/32335859

Zobrazit plný text záznamu

Use of rituximab in adults with relapsing–remitting multiple sclerosis: a systematic literature review

Autor: Barinder Singh, Gerard Harty, M.K. Siddiqui, Christiaan Veraart, Schiffon L Wong, Sumeet Attri

Objective: Rituximab is used as an off-label treatment for relapsing–remitting multiple sclerosis (RRMS); however, the comparative efficacy and safety of rituximab versus currently licensed disease-modifying drugs (DMDs) for RRMS is unknown. A syst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd99be14bab6a6ac561713601459b79

Zobrazit plný text záznamu

Pregnancy outcome in women with intrahepatic cholestasis of pregnancy

Autor: Sita Thakur, Sumeet Attri, Shashi Kant, Ajay Sood

Publikováno v: International Journal of Research in Medical Sciences. 8:2232

Background: Intrahepatic cholestasis of pregnancy is a multifactorial condition of pregnancy diagnosed when otherwise unexplained pruritus with abnormal liver function test and neither of which has an alternative cause. The most appropriate gestation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e4e9b4fb67960cc0045f3a086af7f6f1
https://doi.org/10.18203/2320-6012.ijrms20202273

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání